Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate.
López-Ferrer
Anna
A
Puig
Luis
L
Moreno
Gerardo
G
Camps-Fresneda
Alejandro
A
Palou
José
J
Alomar
Agustín
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D017514:Pityriasis Lichenoides / Q000139:chemically induced* / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab; D008727:Methotrexate